Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
View Session ViewAttendees 39

Adult ID

Global ID

Investigative ID

HIV-STD-TB

Pediatric ID

Trainee

Transplant
Meet-the-Professor

120 - Top 10 papers in Medical Mycology

Saturday, October 2, 2021
10:00 AM - 11:15 AM EDT

    Moderator(s)

  • Joshua Nosanchuk, MD

    Professor and Senior Associate Dean
    Albert Einstein College of Medicine
    Bronx, NY, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

    • Speaker(s)

  • Thomas Patterson, MD

    Professor and Chief, Infectious Diseases
    University of Texas Health San Antonio
    San Antonio, TX, United States

    Astellas (Individual(s) Involved: Self): Research Grant or Support; Basilea (Individual(s) Involved: Self): Consultant; Cidara (Individual(s) Involved: Self): Scientific Research Study Investigator; F2G (Individual(s) Involved: Self): Advisor or Review Panel member, Scientific Research Study Investigator; Gilead (Individual(s) Involved: Self): Consultant, Scientific Research Study Investigator; Merck (Individual(s) Involved: Self): Advisor or Review Panel member; Pfizer (Individual(s) Involved: Self): Consultant; SCYNEXIS, Inc. (Individual(s) Involved: Self): Advisor or Review Panel member; Sfunga (Individual(s) Involved: Self): Consultant

  • Bettina Fries, MD/FIDSA

    Chief, Division of Infectious Diseases
    Stony Brook University Hospital
    Stony Brook, NY, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

Participants should be aware of the following financial/non-financial relationships:
Joshua D. Nosanchuk, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Thomas F. Patterson, MD: Astellas (Individual(s) Involved: Self): Research Grant or Support; Basilea (Individual(s) Involved: Self): Consultant; Cidara (Individual(s) Involved: Self): Scientific Research Study Investigator; F2G (Individual(s) Involved: Self): Advisor or Review Panel member, Scientific Research Study Investigator; Gilead (Individual(s) Involved: Self): Consultant, Scientific Research Study Investigator; Merck (Individual(s) Involved: Self): Advisor or Review Panel member; Pfizer (Individual(s) Involved: Self): Consultant; SCYNEXIS, Inc. (Individual(s) Involved: Self): Advisor or Review Panel member; Sfunga (Individual(s) Involved: Self): Consultant
Bettina C. Fries, MD/FIDSA: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-21-001-H01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:
  • discuss the year's important clinical advances in mycology that have the potential to impact clinical care and foster new research
  • describe strategies to apply new data to further discovery or clinical practices in mycology
  • discuss the year's important biomedical discoveries in mycology that have the potential to impact clinical care and foster new research in mycology

Presentations:

  • Top 10 Papers in Medical Mycology: Clinical Focus

    Speaker: Thomas F. Patterson, MD – University of Texas Health San Antonio

  • Top 10 Papers in Medical Mycology: Research Focus

    Speaker: Bettina C. Fries, MD/FIDSA – Stony Brook University Hospital